Join the club for FREE to access the whole archive and other member benefits.

Israel's CollPlant to improve 3D bioprinted organs

20-Oct-2017

Key points from article :

Received $5M investment from Martin Schlaff's Alpha Capital.

Bioprinted tissues based on technology that transforms plant-based products.

Plants able to produce human collagen - the most common protein in the body.

Bioink can be processed through a bioprinter and built up into scaffold.

Mentioned in this article:

Click on resource name for more details.

CollPlant

Regenerative and aesthetic medicine company focused on medical aesthetics and 3D bioprinting of tissues and organs.

Yehiel Tal

Chief Executive Officer at CollPlant.

Topics mentioned on this page:
3D Printing